p(1),p(5)-di(adenosine-5'-)pentaphosphate has been researched along with isoproterenol in 1 studies
| Studies (p(1),p(5)-di(adenosine-5'-)pentaphosphate) | Trials (p(1),p(5)-di(adenosine-5'-)pentaphosphate) | Recent Studies (post-2010) (p(1),p(5)-di(adenosine-5'-)pentaphosphate) | Studies (isoproterenol) | Trials (isoproterenol) | Recent Studies (post-2010) (isoproterenol) |
|---|---|---|---|---|---|
| 215 | 2 | 26 | 30,780 | 803 | 2,640 |
| Protein | Taxonomy | p(1),p(5)-di(adenosine-5'-)pentaphosphate (IC50) | isoproterenol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.246 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.333 | |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 1.77 | |
| Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
| Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
| Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | 0.6667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arvola, L; Bertelsen, G; Hassaf, D; Ytrehus, K | 1 |
1 other study(ies) available for p(1),p(5)-di(adenosine-5'-)pentaphosphate and isoproterenol
| Article | Year |
|---|---|
Positive inotropic and sustained anti-beta-adrenergic effect of diadenosine pentaphosphate in human and guinea pig hearts. Role of dinucleotide receptors and adenosine receptors.
Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Dinucleoside Phosphates; Female; Guinea Pigs; Heart Atria; Humans; Isoproterenol; Male; Myocardial Contraction; Papillary Muscles; Purinergic Antagonists; Receptors, Purinergic P2; Suramin; Theophylline; Vasoconstrictor Agents | 2004 |